ArticleDrug design, development and therapy2024

Assessing the Impact of Morphine on Adverse Outcomes in ACS Patients Treated with P2Y12 Inhibitors: Insights from Multiple Real-World Evidence.

Chenxi Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.